Technology News and Research

RSS

Foamix's novel foam technology awarded US patent

Foamix Ltd., a leading developer of topical foams for dermatology and gynecology, announced today that it has been awarded US Patent #7575739 pertaining to its foam technology. The patent covers unique foam compositions, suitable for the treatment of heat and chemical burns, wounds, bacterial, fungal and viral infections.

24 Aug 2009

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and its co-plaintiffs today announced that the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”) has granted their petition for rehearing en banc and has vacated its April 2009 decision in the appeal that Eli Lilly and Co. filed in 2008. All twelve judges of the Federal Circuit will now rehear and reassess the merits of Lilly’s appeal.

24 Aug 2009

MIT to honor Dr. Khine of Shrink Nanotechnologies as one of the top 35 global innovators

Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB: INKN), an innovative nanotechnology company that develops products, licenses its patent-pending technologies and acquires related assets in three core vertical markets: (i) solar energy production, (ii) medical diagnostics and sensors and (iii) biotechnology research and development tools, today announced that Dr. Michelle Khine, Ph.D., the scientific founder of Shrink’s nanofabrication platform, was named by MIT Technology Review as one of the top 35 global innovators under the age of 35.

24 Aug 2009

XSpray Microparticles launches GMP production facility in Sweden

Karolinska Development (publ), managing one of the largest portfolios of life science research companies in Europe, announced that XSpray Microparticles AB has launched a GMP production facility in Malmo, Sweden. In addition to offering particle development and characterization services, XSpray can now provide customers with high quality drug particles and powders for use in their clinical studies.

24 Aug 2009

SQI Diagnostics continues discussions with the FDA to market it's SQiDworks Diagnostics Platform in the US

SQI Diagnostics Inc. (TSX-V: SQD), a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the third quarter ended June 30, 2009.

24 Aug 2009

Covidien introduces Leak Compensation software for Puritan Bennett 840 ventilator

Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the global launch of its Leak Compensation software option for the Puritan Bennett 840™ ventilator. This new feature will provide a ventilation solution in high-leak environments, particularly in non-invasive ventilation where air leaks associated with the use of masks, nasal prongs, and nasal pillows are common.

24 Aug 2009

Infologix issues SEC proxy statement regarding proposed recapitalization plan

InfoLogix, Inc. ("InfoLogix" or the "Company"), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it has filed a preliminary proxy statement with the U.S. Securities and Exchange Commission ("SEC") in connection with a special meeting of stockholders of InfoLogix to approve a proposed recapitalization plan of the Company and certain related matters.

24 Aug 2009

$1.1 million funds will help make critical enhancements to Integrated Medical Systems' MedEx 1000 system

Integrated Medical Systems, Inc., a medical technology systems integrator transforming critical care, announced that it has received $1.1 million in funding from the U.S. Department of Defense for additional enhancements of the company's MedEx 1000(TM) "suitcase" intensive care unit (ICU).

24 Aug 2009

GoHealthInsurance.com offers comprehensive health insurance coverage

Health reform is on the forefront of everyone's minds. Last month in his weekly address, President Barack Obama touted health insurance "exchanges" which offer Americans a one-stop shopping destination for health coverage.

24 Aug 2009

EndoChoice announces completion of Series B financing

EndoChoice, Inc., an emerging leader in GI endoscopy products and services, announced today that it completed its Series B financing. The financing was co-led by Council Ventures and Series A lead investor River Cities Capital Funds. With more than 500 GI products and services, EndoChoice is bringing new efficiencies and innovation to the GI professional.

24 Aug 2009

UCLA's Laboratory of Neuro Imaging awarded $1.9 million NIH ARRA grant

UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.

24 Aug 2009

Profibrix raises funds for clinical and preclinical development

ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the successful closing of a US $11 million series B investment. The financing round was led by new investor Gilde Healthcare Partners, a leading European life sciences investor, who joins existing investor Index Ventures. Dirk Kersten from Gilde will join the company's Supervisory Board.

24 Aug 2009

Micrus Endovascular Corporation and Flexible Stenting Solutions to jointly develop flow diversion technology for neurovascular indications

Micrus Endovascular Corporation and privately held Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the signing of an exclusive agreement to jointly develop a flow diversion technology for neurovascular indications using both Micrus and Flexible Stenting Solutions technology, development capabilities and intellectual property.

24 Aug 2009

Grants to grease e-health transition renew optimistic skepticism

Administration officials announced a new stimulus-funded federal grant program that will deploy $1.2 billion to help build health information technology infrastructure on Thursday.

24 Aug 2009

Two key circuits for controlling the cell's ability identified by UCSF researchers

UCSF researchers have identified the two key circuits that control a cell's ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.

24 Aug 2009

University of Michigan discovers new gene target for treating idiopathic pulmonary fibrosis

Researchers at the University of Michigan have discovered that targeting of a novel gene utilizing genetic and pharmacologic strategies was successful in treating pulmonary fibrosis in mice and will be developed for future testing in humans.

24 Aug 2009

Sigma-Aldrich scientists to leverage proprietary gene editing technology to develop genetically-engineered rodent research models

Sigma-Aldrich(R) (Nasdaq: SIAL) announced today that scientists at its new Sigma Advanced Genetic Engineering (SAGE(TM)) Labs in St. Louis will leverage its exclusive CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (www.compozrzfn.com) to define, develop and offer a new generation of genetically-engineered rodent research models. Such models are commonly used to study disease states in humans and play a key role in the drug discovery process.

24 Aug 2009

Research reveals that diarrheal bacteria can cause colon cancers

Johns Hopkins scientists say they have figured out how bacteria that cause diarrhea may also be the culprit in some colon cancers. The investigators say that strains of the common Bacteroides fragilis (ETBF) dupe immune system cells into permitting runaway colon tissue inflammation, a precursor for malignant growth.

24 Aug 2009

Japanese research reveals that neural circuits in the mouse brain actively rearrange after stroke

Japanese research group led by Professor Junichi Nabekura in National Institute for Physiological Sciences, NIPS, Japan, found that, after cerebral stroke in one side of the mouse brain, another side of the brain rewires its neural circuits to recuperate from damaged neural function. The Japan Science and Technology Agency (JST) supported this study. They report their finding in Journal of Neuroscience, on August 12, 2009.

24 Aug 2009

Marin Catholic High School's new SAS system reduces the presence of illness-causing microorganisms

Marin Catholic High School (MCHS) and CSG, the worldwide leader in environmentally-beneficial surface treatments, today announced the school is the Bay Area's first education facility to integrate the Surface Antimicrobial System (SAS). The most environmentally friendly and long-lasting treatment of its kind, SAS has transformed 10,000 square feet of high-touch surfaces in Marin's athletic facility into materials that continuously inhibit the growth of harmful bacteria, mold, and fungi for three years.

24 Aug 2009

Technology News and Research

Foamix's novel foam technology awarded US patent

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

MIT to honor Dr. Khine of Shrink Nanotechnologies as one of the top 35 global innovators

XSpray Microparticles launches GMP production facility in Sweden

SQI Diagnostics continues discussions with the FDA to market it's SQiDworks Diagnostics Platform in the US

Covidien introduces Leak Compensation software for Puritan Bennett 840 ventilator

Infologix issues SEC proxy statement regarding proposed recapitalization plan

$1.1 million funds will help make critical enhancements to Integrated Medical Systems' MedEx 1000 system

GoHealthInsurance.com offers comprehensive health insurance coverage

EndoChoice announces completion of Series B financing

UCLA's Laboratory of Neuro Imaging awarded $1.9 million NIH ARRA grant

Profibrix raises funds for clinical and preclinical development

Micrus Endovascular Corporation and Flexible Stenting Solutions to jointly develop flow diversion technology for neurovascular indications

Grants to grease e-health transition renew optimistic skepticism

Two key circuits for controlling the cell's ability identified by UCSF researchers

University of Michigan discovers new gene target for treating idiopathic pulmonary fibrosis

Sigma-Aldrich scientists to leverage proprietary gene editing technology to develop genetically-engineered rodent research models

Research reveals that diarrheal bacteria can cause colon cancers

Japanese research reveals that neural circuits in the mouse brain actively rearrange after stroke

Marin Catholic High School's new SAS system reduces the presence of illness-causing microorganisms

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News